医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

The First Smart Dispensing Robot EVV220 in Asia at Vejthani Hospital

2012年10月17日 PM05:55
このエントリーをはてなブックマークに追加


 

BANGKOK

Vejthani Hospital Bangkok offers cutting-edge technologies, with the ability to operate maximum safety and accuracy. We are thrilled to be the first hospital in Asia to have the new modern advanced technology, The Smart Dispensing Robot EVV220.

Vejthani Hospital Smart Dispensing Robot EVV220 is designed to reduce or eliminate the risk of cross contamination, simplifies a filling process, easy to use, incorporate and keep.

Advantages of Smart Dispensing Robot EVV220

  • The doctor’s order transmits directly to the Smart Robot.
  • Robotic Direct Fill
    - Vials are filled directly from the drug cassette, eliminating the risk of contamination and calibration errors.
  • Complete and Accurate Dispensing Robot
    - Doctor’s order transmits directly to the Smart Robot and verifies the barcode with the barcode scanner to locate corresponding vials.
  • The barcode scanner assures the right medication is refilled into its proper cassette.

Vejthani Hospital Bangkok became the first hospital in Asia to offer Smart Dispensing Robot EVV220, thus can improve the quality services offered in both inpatients and outpatients as well. Indeed modern advanced technology is going to have an even tremendous part in terms of quality healthcare services both local and international countries. If you want more information don’t hesitate to contact us.

Please Visit: Smart Dispensing Robot EVV220

CONTACT

Vejthani
Hospital

Harriet Marie, (+66)85-223-8888
Nurse
Information Online
webmaster@vejthani.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • 武田薬品が米国臨床腫瘍学会(ASCO)と欧州血液学会(EHA)の年次総会でオンコロジーの広範なポートフォリオとパイプラインのデータを発表
  • ResMed赞助的研究显示,采用居家吸氧与居家无创通气相结合治疗COPD具有成本效益
  • 武田在美国临床肿瘤学会(ASCO)和欧洲血液学会(EHA)年会上重点介绍其强大的肿瘤产品阵容和后续产品线数据
  • AVITA Medical Announces Presentation at ISPOR Meeting Validating Acute Burn Health Economic Model
  • GRAIL Announces $300 Million Raised in Oversubscribed Series C Financing